Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30073478HIVENSG00000068366.21protein_codingACSL4NoNo2182O60488
TVIS30073479HIVENSG00000068366.21protein_codingACSL4NoNo2182O60488
TVIS30073480HIVENSG00000068366.21protein_codingACSL4NoNo2182O60488
TVIS20064599HPVENSG00000068366.21protein_codingACSL4NoNo2182O60488
TVIS44030218HTLV-1ENSG00000068366.21protein_codingACSL4NoNo2182O60488
TVIS44048501HTLV-1ENSG00000068366.21protein_codingACSL4NoNo2182O60488
TCGA Plot Options
Drug Information
GeneACSL4
DrugBank IDDB00412
Drug NameRosiglitazone
Target IDBE0000996
UniProt IDO60488
Regulation Typeinhibitor
PubMed IDs17259370
CitationsAskari B, Kanter JE, Sherrid AM, Golej DL, Bender AT, Liu J, Hsueh WA, Beavo JA, Coleman RA, Bornfeldt KE: Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes. 2007 Apr;56(4):1143-52. Epub 2007 Jan 26.
GroupsApproved; Investigational
Direct ClassificationPhenol ethers
SMILESCN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
PathwaysRosiglitazone Metabolism Pathway
PharmGKBPA451283
ChEMBLCHEMBL121